Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 3
1994 4
1995 6
1996 3
1997 5
1998 1
2001 1
2002 1
2003 1
2005 2
2006 3
2007 5
2008 6
2009 9
2010 8
2011 4
2012 2
2013 9
2014 5
2015 2
2016 6
2017 9
2018 8
2019 7
2020 11
2021 20
2022 14
2023 17
2024 8
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

156 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial.
Tuttle KR, Hauske SJ, Canziani ME, Caramori ML, Cherney D, Cronin L, Heerspink HJL, Hugo C, Nangaku M, Rotter RC, Silva A, Shah SV, Sun Z, Urbach D, de Zeeuw D, Rossing P; ASi in CKD group. Tuttle KR, et al. Lancet. 2024 Jan 27;403(10424):379-390. doi: 10.1016/S0140-6736(23)02408-X. Epub 2023 Dec 15. Lancet. 2024. PMID: 38109916 Clinical Trial.
Anaemia and quality of life in chronic kidney disease: a consensus document from the European Anaemia of CKD Alliance.
Dasgupta I, Bagnis CI, Floris M, Furuland H, Zurro DG, Gesualdo L, Heirman N, Minutolo R, Pani A, Portolés J, Rosenberger C, Alvarez JES, Torres PU, Vanholder RC, Wanner C; European Anaemia of aCKD Alliance. Dasgupta I, et al. Among authors: portoles j. Clin Kidney J. 2024 Jul 4;17(8):sfae205. doi: 10.1093/ckj/sfae205. eCollection 2024 Aug. Clin Kidney J. 2024. PMID: 39135937 Free PMC article. Review.
Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies.
Barratt J, Dellanna F, Portoles J, Choukroun G, De Nicola L, Young J, Dimković N, Reusch M. Barratt J, et al. Among authors: portoles j. Adv Ther. 2023 Apr;40(4):1546-1559. doi: 10.1007/s12325-023-02433-0. Epub 2023 Feb 7. Adv Ther. 2023. PMID: 36749544 Free PMC article. Clinical Trial.
On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome.
Huerta A, Arjona E, Portoles J, Lopez-Sanchez P, Cavero T, Fernandez-Cusicanqui J, Blasco M, Cabello V, Calvo N, Diaz M, Herrero-Goñi M, Aguirre M, Elías S, Alcaide MP, Ramos N, Sellares J, Rodríguez de Córdoba S. Huerta A, et al. Among authors: portoles j. Kidney Int. 2023 Oct;104(4):851-855. doi: 10.1016/j.kint.2023.07.020. Epub 2023 Aug 9. Kidney Int. 2023. PMID: 37567446 Free article. No abstract available.
156 results